insulin detemir + human soluble insulin

**Insulin detemir + human soluble insulin** is a combination of two injectable insulin preparations for the management of diabetes mellitus. **Insulin detemir** is a long-acting human insulin analogue, produced by recombinant DNA technology, modified to bind albumin and thereby exhibit a slow absorption and prolonged activity. **Human soluble insulin** is a short-acting insulin, used to manage postprandial glucose elevations. This combination, though more commonly available as separate injections rather than fixed-dose combos, is designed to mimic both basal and prandial insulin secretion, providing improved blood glucose control in patients with type 1 and type 2 diabetes. Both components act as agonists of the insulin receptor, facilitating glucose uptake and utilization throughout the body.